Moneycontrol PRO
LAMF
LAMF

Ayushman Kumar

Principal Correspondent, Editorial And Content, Moneycontrol

Indian pharma company under fire for Gambia child deaths has a history of selling substandard drugs

TRENDS

Indian pharma company under fire for Gambia child deaths has a history of selling substandard drugs

Gambia cough syrup deaths: Samples sent for testing, results to come in two days

BUSINESS

Gambia cough syrup deaths: Samples sent for testing, results to come in two days

Urgent probe launched into Gambia cough syrup deaths as fatalities report awaited from WHO

TRENDS

Urgent probe launched into Gambia cough syrup deaths as fatalities report awaited from WHO

Centre defends pharma marketing practice code in SC, claims adequacy

TRENDS

Centre defends pharma marketing practice code in SC, claims adequacy

Govt advises manufacturing companies on prices of phosphoric acid

BUSINESS

Govt advises manufacturing companies on prices of phosphoric acid

Heart disease no more an old-age problem, common in the younger population, say cardiologists

HEALTH-AND-FITNESS

Heart disease no more an old-age problem, common in the younger population, say cardiologists

Early intervention in rare disease can save lives, Centre’s policy an encouraging step: Bruno Jolain, Roche India

TRENDS

Early intervention in rare disease can save lives, Centre’s policy an encouraging step: Bruno Jolain, Roche India

Mental healthcare start-up Lissun raises $1 million in pre-seed round from IvyCap ventures

BUSINESS

Mental healthcare start-up Lissun raises $1 million in pre-seed round from IvyCap ventures

Private hospitals concerned over removal of payment clause in revised CGHS empanelment pact

INDIA

Private hospitals concerned over removal of payment clause in revised CGHS empanelment pact

Cadila in talks with Centre, states for supply of three-dose rabies vaccine

INDIA

Cadila in talks with Centre, states for supply of three-dose rabies vaccine

Dementia, as a fallout of COVID-19, emerges as a threat to India’s elderly 

INDIA

Dementia, as a fallout of COVID-19, emerges as a threat to India’s elderly 

J&J to challenge Maharashtra FDA's order cancelling license of its baby powder

HEALTH-TRENDS

J&J to challenge Maharashtra FDA's order cancelling license of its baby powder

‘Not able to sell, what next’: Chemist body asks Johnson and Johnson as FDA orders withdrawal of baby powder from market

TRENDS

‘Not able to sell, what next’: Chemist body asks Johnson and Johnson as FDA orders withdrawal of baby powder from market

'Withdraw baby powder from the market': Maharashtra FDA tells J&J

INDIA

'Withdraw baby powder from the market': Maharashtra FDA tells J&J

Bengaluru's traffic concern for patients, need to make infrastructure sustainable: Doctor who ran to perform surgery

TRENDS

Bengaluru's traffic concern for patients, need to make infrastructure sustainable: Doctor who ran to perform surgery

Injecting local anaesthesia agent around tumour in breast cancer patients can increase cure rates: Study

TRENDS

Injecting local anaesthesia agent around tumour in breast cancer patients can increase cure rates: Study

Biological-E developing Omicron specific vaccine, contemplating it to be used as bivalent jab: Mahima Datla, CEO

HEALTH-TRENDS

Biological-E developing Omicron specific vaccine, contemplating it to be used as bivalent jab: Mahima Datla, CEO

Micro Labs gets clean chit from pharma body on allegations of spending Rs 1,000 crore on Dolo 650

BUSINESS

Micro Labs gets clean chit from pharma body on allegations of spending Rs 1,000 crore on Dolo 650

Zenara pharma launches COVID-19 antiviral pills

TRENDS

Zenara pharma launches COVID-19 antiviral pills

MC Explains | Amid rising cases of cervical cancer, an affordable vaccine that can be a game changer

TRENDS

MC Explains | Amid rising cases of cervical cancer, an affordable vaccine that can be a game changer

Delhi HC grants bail to Eswara Reddy, Pravin Kumar in CDSCO bribery case, says no flight risk

INDIA

Delhi HC grants bail to Eswara Reddy, Pravin Kumar in CDSCO bribery case, says no flight risk

Bharat Biotech's nasal COVID vaccine gets DCGI nod

INDIA

Bharat Biotech's nasal COVID vaccine gets DCGI nod

As Centre readies ‘Heal in India’ portal, hospital chains suggest a slew of measures on medical tourism

TRENDS

As Centre readies ‘Heal in India’ portal, hospital chains suggest a slew of measures on medical tourism

Serum Institute to roll out home-grown cervical cancer vaccine at one-tenth cost

TRENDS

Serum Institute to roll out home-grown cervical cancer vaccine at one-tenth cost

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347